These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 27352591

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Nov 09; 50(44):976-9. PubMed ID: 11724151
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].
    Wichmann O, Ultsch B.
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep 09; 56(9):1260-9. PubMed ID: 23990088
    [Abstract] [Full Text] [Related]

  • 28. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.
    Black SB, Cimino CO, Hansen J, Lewis E, Ray P, Corsaro B, Graepel J, Laufer D.
    Pediatr Infect Dis J; 2006 Apr 09; 25(4):306-11. PubMed ID: 16567981
    [Abstract] [Full Text] [Related]

  • 29. Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts.
    Zimmerman L, Rogalska J, Wannemuehler KA, Haponiuk M, Kosek A, Pauch E, Plonska E, Veltze D, Czarkowski MP, Buddh N, Reef S, Stefanoff P.
    J Infect Dis; 2011 Jul 09; 204 Suppl 1():S389-95. PubMed ID: 21666189
    [Abstract] [Full Text] [Related]

  • 30. [MMR, diphtheria-tetanus and polio vaccination of students in Aargau].
    Roth-Kleiner M, Gnehm HE.
    Praxis (Bern 1994); 1997 Dec 03; 86(49):1934-7. PubMed ID: 9480514
    [Abstract] [Full Text] [Related]

  • 31. Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8 months versus 12 months age in children.
    He H, Chen E, Chen H, Wang Z, Li Q, Yan R, Guo J, Zhou Y, Pan J, Xie S.
    Vaccine; 2014 Jun 30; 32(31):4001-5. PubMed ID: 24837773
    [Abstract] [Full Text] [Related]

  • 32. Financing immunization of adults in the United States.
    Orenstein WA, Mootrey GT, Pazol K, Hinman AR.
    Clin Pharmacol Ther; 2007 Dec 30; 82(6):764-8. PubMed ID: 17971821
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR, Sivertson D, Horan JM, Lindegren ML, Dwyer DM.
    Public Health Rep; 1993 Dec 30; 108(4):431-5. PubMed ID: 8341775
    [Abstract] [Full Text] [Related]

  • 34. The two-dose measles, mumps, and rubella (MMR) immunisation schedule: factors affecting maternal intention to vaccinate.
    Pareek M, Pattison HM.
    Br J Gen Pract; 2000 Dec 30; 50(461):969-71. PubMed ID: 11224968
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. MMR at 9 months: rushing in where others fear to tread?
    Sharma A, Puliyel J.
    Indian Pediatr; 2015 Jan 30; 52(1):80-1. PubMed ID: 25638202
    [No Abstract] [Full Text] [Related]

  • 38. [Vaccination of young children, at school entrance and completion in the Bern canton 1998].
    Maurer AM, Mühlemann K, Seiler AJ.
    Praxis (Bern 1994); 2001 Sep 27; 90(39):1676-84. PubMed ID: 11680120
    [Abstract] [Full Text] [Related]

  • 39. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
    Novaes HM, de Soárez PC, Silva GA, Ayres A, Itria A, Rama CH, Sartori AM, Clark AD, Resch S.
    Vaccine; 2015 May 07; 33 Suppl 1():A135-42. PubMed ID: 25919154
    [Abstract] [Full Text] [Related]

  • 40. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
    Schuster V, Otto W, Maurer L, Tcherepnine P, Pfletschinger U, Kindler K, Soemantri P, Walther U, Macholdt U, Douha M, Pierson P, Willems P.
    Pediatr Infect Dis J; 2008 Aug 07; 27(8):724-30. PubMed ID: 18600190
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.